|
|
Volumn 30, Issue 3, 2002, Pages 211-219
|
|
Clinical evaluation of ramosetron injections in the treatment of cisplatin-induced nausea and vomiting
a
|
|
Author keywords
5 HT3; Anti emesis; Cancer chemotherapy; CDDP; Cisplatin; Efficacy; Ramosetron; Receptor antagonist; Safety
|
|
Indexed keywords
ALKALINE PHOSPHATASE;
ANTINEOPLASTIC AGENT;
BILIRUBIN;
CISPLATIN;
GAMMA GLUTAMYLTRANSFERASE;
PLACEBO;
RAMOSETRON;
SEROTONIN 3 ANTAGONIST;
BENZIMIDAZOLE DERIVATIVE;
SEROTONIN ANTAGONIST;
ANOREXIA;
ARTICLE;
CANCER PATIENT;
CHEMOTHERAPY INDUCED EMESIS;
CLINICAL OBSERVATION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIGESTIVE SYSTEM CANCER;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
DRUG USE;
DRUG WITHDRAWAL;
FEMALE;
HEADACHE;
HUMAN;
HYPERBILIRUBINEMIA;
LEUKOCYTE DISORDER;
LUNG CANCER;
MAJOR CLINICAL STUDY;
MALE;
NAUSEA AND VOMITING;
OVARY CANCER;
PHASE 3 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
TESTIS CANCER;
TREATMENT OUTCOME;
URINARY TRACT CANCER;
UTERUS CANCER;
ADULT;
AGED;
CHEMICALLY INDUCED DISORDER;
MIDDLE AGED;
NAUSEA;
VOMITING;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS;
BENZIMIDAZOLES;
CISPLATIN;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
NAUSEA;
PLACEBOS;
SEROTONIN ANTAGONISTS;
VOMITING;
|
|
EID: 0035988484
PISSN: 03000605
EISSN: None
Source Type: Journal
DOI: 10.1177/147323000203000301 Document Type: Article |
|
Times cited : (8)
|
|
References (27)
|
